Global Blood Therapeutics leads in world sickle cell disease trials
Sickle cell disease comprises a group of inherited disorders caused by mutations of haemoglobin subunit beta.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more